Transaction DateRecipientSharesTypePriceValue
22nd January 2021Christopher P. Stewart8,000Grant/award etc.$6.00$48,000.00
31st July 2020Christopher J Twomey5,000Open or private sale$110.06$550,319.50
31st July 2020Christopher J Twomey2,500Open or private sale$110.00$275,000.00
31st July 2020Christopher J Twomey2,500Bona fide gift$106.53$266,312.50
2nd July 2020Christopher J Twomey2,500Open or private sale$100.02$250,061.50
2nd July 2020Christopher J Twomey3,938Open or private sale$100.20$394,573.82
2nd July 2020Christopher J Twomey1,062Open or private sale$101.17$107,438.40
2nd July 2020Christopher J Twomey2,500Bona fide gift$101.26$253,150.00
7th May 2020Christopher J Twomey5,000Open or private sale$90.04$450,213.50
7th May 2020Christopher J Twomey2,500Bona fide gift$88.60$221,487.50
Bionano Genomics
Bionano Genomics logo

Based on disclosure changes, sentiment, insider trading and news impact we give a rating of 10/10.

BioNano Genomics, Inc. is a life sciences instrumentation company, which focuses on genome analysis space. The firm engages in the development and marketing of Saphyr system.

Ticker: BNGO
Sector: Healthcare
Industry: Diagnostics & Research
SEC Central Index Key (CIK): 1411690
Employees: 77
Exchange: NASDAQ
Auditor Opinion:

Disclosure Language changes
Red Flags
Cash at Carrying Value: $17 M (0%)
Inventory, Net: $3 M (0%)
Assets, Current: $25 M (-12%)
Property, Plant and Equipment, Net: $3 M (30%)
Assets: $27 M (-9%)
Long-term Debt, Current Maturities: $14 M (-30%)
Accounts Payable, Current: $3 M (5%)
Accrued Liabilities, Current: $2 M (-24%)
Liabilities, Current: $20 M (-26%)
Other Liabilities, Noncurrent: $0 (-100%)
Liabilities: $21 M (-19%)
Common Stock, Value, Issued: $9 Th (200%)
Common Stock, Shares, Issued: $92 M (168%)
Additional Paid in Capital, Common Stock: $127 M (19%)
Retained Earnings (Accumulated Deficit): $121 M (0%)
Stockholders' Equity (Parent): $6 M (0%)
Liabilities and Equity: $27 M (-9%)
Revenue: $1 M (0%)
Cost of Revenue: $603 Th (-58%)
Research and Development: $2 M (-52%)
Operating Income/Loss: $7 M (-56%)
Other Income, net: $634 Th (-53%)
Provision for income taxes: $5 Th (-50%)